So many Americans struggle to achieve weight loss success, with the existing programs and methods out there.
After all, 70% of Americans are currently overweight - with one-third of those being obese!
On June 4, 2021 FDA approval was granted for the first new class of weight-loss medications, Semaglutide or GLP-1.
This new medication has shown such great results for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), for use in addition to a reduced calorie diet and increased physical activity.
To receive email releases and coupons, simply provide us with your email address below.
DESIGNED AND POWERED BY